{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:20:27Z","timestamp":1788189627319,"version":"build-2803163510"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12185-026-04251-w","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:16:39Z","timestamp":1784214999000},"page":"311-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gene editing of hematopoietic stem cells: applications and advances"],"prefix":"10.1007","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1230-2243","authenticated-orcid":false,"given":"Qiuyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genyue","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"3","key":"4251_CR1","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","volume":"93","author":"YG Kim","year":"1996","unstructured":"Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A. 1996;93(3):1156\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4251_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100800","author":"M Laurent","year":"2024","unstructured":"Laurent M, Geoffroy M, Pavani G, Guiraud S. CRISPR-based gene therapies: from preclinical to clinical treatments. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13100800.","journal-title":"Cells"},{"issue":"5","key":"4251_CR3","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.ymthe.2025.03.016","volume":"33","author":"J Ball","year":"2025","unstructured":"Ball J, Bradley A, Le A, Tisdale JF, Uchida N. Current and future treatments for sickle cell disease: from hematopoietic stem cell transplantation to in vivo gene therapy. Mol Ther. 2025;33(5):2172\u201391.","journal-title":"Mol Ther"},{"issue":"11","key":"4251_CR4","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1073\/pnas.1913445117","volume":"117","author":"IE Ivanov","year":"2020","unstructured":"Ivanov IE, Wright AV, Cofsky JC, Aris KDP, Doudna JA, Bryant Z. Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling. Proc Natl Acad Sci U S A. 2020;117(11):5853\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7519","key":"4251_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nature13579","volume":"513","author":"C Anders","year":"2014","unstructured":"Anders C, Niewoehner O, Duerst A, Jinek M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature. 2014;513(7519):569\u201373.","journal-title":"Nature"},{"key":"4251_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/bios15100660","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Cho IH, Kadam US. CRISPR-Cas-based diagnostics in biomedicine: principles, applications, and future trajectories. Biosensors. 2025. https:\/\/doi.org\/10.3390\/bios15100660.","journal-title":"Biosensors"},{"issue":"6488","key":"4251_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton RT, Christie KA, Whittaker MN, Kleinstiver BP. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science. 2020;368(6488):290\u20136.","journal-title":"Science"},{"issue":"6408","key":"4251_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1126\/science.aas9129","volume":"361","author":"H Nishimasu","year":"2018","unstructured":"Nishimasu H, Shi X, Ishiguro S, Gao L, Hirano S, Okazaki S, et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science. 2018;361(6408):1259\u201362.","journal-title":"Science"},{"issue":"11","key":"4251_CR9","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41589-023-01380-9","volume":"19","author":"T Wu","year":"2023","unstructured":"Wu T, Liu C, Zou S, Lyu R, Yang B, Yan H, et al. An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity. Nat Chem Biol. 2023;19(11):1384\u201393.","journal-title":"Nat Chem Biol"},{"key":"4251_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-025-01236-y","author":"S Levesque","year":"2025","unstructured":"Levesque S, Bauer DE. CRISPR-based therapeutic genome editing for inherited blood disorders. Nat Rev Drug Discov. 2025. https:\/\/doi.org\/10.1038\/s41573-025-01236-y.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"4251_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.molcel.2021.12.026","volume":"82","author":"TS Nambiar","year":"2022","unstructured":"Nambiar TS, Baudrier L, Billon P, Ciccia A. CRISPR-based genome editing through the lens of DNA repair. Mol Cell. 2022;82(2):348\u201388.","journal-title":"Mol Cell"},{"issue":"3","key":"4251_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","volume":"24","author":"PJ Chen","year":"2023","unstructured":"Chen PJ, Liu DR. Prime editing for precise and highly versatile genome manipulation. Nat Rev Genet. 2023;24(3):161\u201377.","journal-title":"Nat Rev Genet"},{"issue":"7603","key":"4251_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533(7603):420\u20134.","journal-title":"Nature"},{"issue":"1-2","key":"4251_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2016.10.044","volume":"168","author":"AC Komor","year":"2017","unstructured":"Komor AC, Badran AH, Liu DR. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell. 2017;168(1\u20132):20\u201336.","journal-title":"Cell"},{"issue":"7866","key":"4251_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","volume":"595","author":"GA Newby","year":"2021","unstructured":"Newby GA, Yen JS, Woodard KJ, Mayuranathan T, Lazzarotto CR, Li Y, et al. Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature. 2021;595(7866):295\u2013302.","journal-title":"Nature"},{"issue":"7681","key":"4251_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature. 2017;551(7681):464\u201371.","journal-title":"Nature"},{"issue":"7","key":"4251_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020;38(7):824\u201344.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"4251_CR18","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","volume":"38","author":"NM Gaudelli","year":"2020","unstructured":"Gaudelli NM, Lam DK, Rees HA, Sol\u00e1-Esteves NM, Barrera LA, Born DA, et al. Directed evolution of adenine base editors with increased activity and therapeutic application. Nat Biotechnol. 2020;38(7):892\u2013900.","journal-title":"Nat Biotechnol"},{"key":"4251_CR19","doi-asserted-by":"publisher","first-page":"15790","DOI":"10.1038\/ncomms15790","volume":"8","author":"HA Rees","year":"2017","unstructured":"Rees HA, Komor AC, Yeh WH, Caetano-Lopes J, Warman M, Edge ASB, et al. Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery. Nat Commun. 2017;8:15790.","journal-title":"Nat Commun"},{"issue":"6","key":"4251_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41592-020-0832-x","volume":"17","author":"E Zuo","year":"2020","unstructured":"Zuo E, Sun Y, Yuan T, He B, Zhou C, Ying W, et al. A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects. Nat Methods. 2020;17(6):600\u20134.","journal-title":"Nat Methods"},{"key":"4251_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.omtn.2022.07.026","volume":"29","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Tao W, Huang S, Sun W, Wang Y, Jiang W, et al. Engineering an adenine base editor in human embryonic stem cells with minimal DNA and RNA off-target activities. Mol Ther Nucleic Acids. 2022;29:502\u201310.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"4251_CR22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","volume":"38","author":"JL Doman","year":"2020","unstructured":"Doman JL, Raguram A, Newby GA, Liu DR. Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat Biotechnol. 2020;38(5):620\u20138.","journal-title":"Nat Biotechnol"},{"issue":"7785","key":"4251_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576(7785):149\u201357.","journal-title":"Nature"},{"issue":"7","key":"4251_CR24","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41587-024-02394-x","volume":"43","author":"X Lei","year":"2025","unstructured":"Lei X, Huang A, Chen D, Wang X, Ji R, Wang J, et al. Rapid generation of long, chemically modified pegRNAs for prime editing. Nat Biotechnol. 2025;43(7):1156\u201367.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"4251_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1089\/crispr.2021.0080","volume":"5","author":"R Gao","year":"2022","unstructured":"Gao R, Fu ZC, Li X, Wang Y, Wei J, Li G, et al. Genomic and transcriptomic analyses of prime editing guide RNA-independent off-target effects by prime editors. CRISPR J. 2022;5(2):276\u201393.","journal-title":"CRISPR J"},{"issue":"6","key":"4251_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41592-023-01859-2","volume":"20","author":"SQ Liang","year":"2023","unstructured":"Liang SQ, Liu P, Ponnienselvan K, Suresh S, Chen Z, Kramme C, et al. Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tag. Nat Methods. 2023;20(6):898\u2013907.","journal-title":"Nat Methods"},{"issue":"22","key":"4251_CR27","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","volume":"184","author":"PJ Chen","year":"2021","unstructured":"Chen PJ, Hussmann JA, Yan J, Knipping F, Ravisankar P, Chen PF, et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 2021;184(22):5635-52.e29.","journal-title":"Cell"},{"issue":"6","key":"4251_CR28","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41587-023-01915-4","volume":"42","author":"M Fiumara","year":"2024","unstructured":"Fiumara M, Ferrari S, Omer-Javed A, Beretta S, Albano L, Canarutto D, et al. Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat Biotechnol. 2024;42(6):877\u201391.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"4251_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41587-020-0677-y","volume":"39","author":"HK Kim","year":"2021","unstructured":"Kim HK, Yu G, Park J, Min S, Lee S, Yoon S, et al. Predicting the efficiency of prime editing guide RNAs in human cells. Nat Biotechnol. 2021;39(2):198\u2013206.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4251_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02458-0","volume":"22","author":"Y Li","year":"2021","unstructured":"Li Y, Chen J, Tsai SQ, Cheng Y. Easy-Prime: a machine learning-based prime editor design tool. Genome Biol. 2021;22(1):235.","journal-title":"Genome Biol"},{"issue":"4","key":"4251_CR31","volume":"73","author":"G Behrouzian Fard","year":"2025","unstructured":"Behrouzian Fard G, Ahmadi MH, Gholamin M, Hosseini Bafghi M. CRISPR-Cas9: a prominent genome editing tool in the management of inherited blood disorders and hematological malignancies. Curr Res Transl Med. 2025;73(4):103531.","journal-title":"Curr Res Transl Med"},{"issue":"1","key":"4251_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ymthe.2018.10.008","volume":"27","author":"A Lattanzi","year":"2019","unstructured":"Lattanzi A, Meneghini V, Pavani G, Amor F, Ramadier S, Felix T, et al. Optimization of CRISPR\/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements. Mol Ther. 2019;27(1):137\u201350.","journal-title":"Mol Ther"},{"issue":"2","key":"4251_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DB Cox","year":"2015","unstructured":"Cox DB, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015;21(2):121\u201331.","journal-title":"Nat Med"},{"key":"4251_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf767","author":"S Andersen","year":"2025","unstructured":"Andersen S, Wolff JH, Skov TW, Janns JH, Davis LJ, Haldrup JH, et al. Gene editing in hematopoietic stem cells by co-delivery of Cas9\/sgRNA ribonucleoprotein and templates for homology-directed repair in \u201call-in-one\u201d lentivirus-derived nanoparticles. Nucleic Acids Res. 2025. https:\/\/doi.org\/10.1093\/nar\/gkaf767.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4251_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2211068213494388","volume":"19","author":"JM Meacham","year":"2014","unstructured":"Meacham JM, Durvasula K, Degertekin FL, Fedorov AG. Physical methods for intracellular delivery: practical aspects from laboratory use to industrial-scale processing. SLAS Technol. 2014;19(1):1\u201318.","journal-title":"SLAS Technol"},{"issue":"1","key":"4251_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ymthe.2023.10.023","volume":"32","author":"J Yao","year":"2024","unstructured":"Yao J, Atasheva S, Wagner N, Di Paolo NC, Stewart PL, Shayakhmetov DM. Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform. Mol Ther. 2024;32(1):103\u201323.","journal-title":"Mol Ther"},{"issue":"1","key":"4251_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03848-4","volume":"15","author":"Z Molaei","year":"2024","unstructured":"Molaei Z, Jabbarpour Z, Omidkhoda A, Ahmadbeigi N. Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells. Stem Cell Res Ther. 2024;15(1):233.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"4251_CR38","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1039\/D1BM01658J","volume":"10","author":"Y Lin","year":"2022","unstructured":"Lin Y, Wagner E, L\u00e4chelt U. Non-viral delivery of the CRISPR\/Cas system: DNA versus RNA versus RNP. Biomater Sci. 2022;10(5):1166\u201392.","journal-title":"Biomater Sci"},{"issue":"12","key":"4251_CR39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078\u201394.","journal-title":"Nat Rev Mater"},{"issue":"7","key":"4251_CR40","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","volume":"23","author":"D Shi","year":"2023","unstructured":"Shi D, Toyonaga S, Anderson DG. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 2023;23(7):2938\u201344.","journal-title":"Nano Lett"},{"issue":"9","key":"4251_CR41","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2013-11-540641","volume":"123","author":"F Amirache","year":"2014","unstructured":"Amirache F, L\u00e9vy C, Costa C, Mangeot PE, Torbett BE, Wang CX, et al. Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood. 2014;123(9):1422\u20134.","journal-title":"Blood"},{"key":"4251_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2021.604371","volume":"3","author":"A Gutierrez-Guerrero","year":"2021","unstructured":"Gutierrez-Guerrero A, Abrey Recalde MJ, Mangeot PE, Costa C, Bernadin O, P\u00e9rian S, et al. Baboon Envelope Pseudotyped \u201cNanoblades\u201d Carrying Cas9\/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34(+) Cells and Knock-in of AAV6-Encoded Donor DNA in CD34(+) Cells. Front Genome Ed. 2021;3:604371.","journal-title":"Front Genome Ed"},{"issue":"17-18","key":"4251_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1089\/hum.2024.105","volume":"35","author":"JH Janns","year":"2024","unstructured":"Janns JH, Mikkelsen JG. Gene editing by ferrying of CRISPR\/Cas ribonucleoprotein complexes in enveloped virus-derived particles. Hum Gene Ther. 2024;35(17\u201318):604\u201316.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"4251_CR44","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","volume":"10","author":"KS Hanlon","year":"2019","unstructured":"Hanlon KS, Kleinstiver BP, Garcia SP, Zaborowski MP, Volak A, Spirig SE, et al. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat Commun. 2019;10(1):4439.","journal-title":"Nat Commun"},{"issue":"10","key":"4251_CR45","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.stem.2022.09.001","volume":"29","author":"S Ferrari","year":"2022","unstructured":"Ferrari S, Jacob A, Cesana D, Laugel M, Beretta S, Varesi A, et al. Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells. Cell Stem Cell. 2022;29(10):1428-44.e9.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"4251_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41587-024-02171-w","volume":"43","author":"FP Suchy","year":"2025","unstructured":"Suchy FP, Karigane D, Nakauchi Y, Higuchi M, Zhang J, Pekrun K, et al. Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors. Nat Biotechnol. 2025;43(2):204\u201313.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4251_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101334","volume":"32","author":"CR Luthers","year":"2024","unstructured":"Luthers CR, Ha SM, Mittelhauser A, Morselli M, Long JD, Kuo CY, et al. DNA contamination within recombinant adeno-associated virus preparations correlates with decreased CD34(+) cell clonogenic potential. Mol Ther Methods Clin Dev. 2024;32(4):101334.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4251_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.omtn.2019.05.025","volume":"17","author":"S Pattabhi","year":"2019","unstructured":"Pattabhi S, Lotti SN, Berger MP, Singh S, Lux CT, Jacoby K, et al. In vivo outcome of homology-directed repair at the HBB gene in HSC using alternative donor template delivery methods. Mol Ther Nucleic Acids. 2019;17:277\u201388.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4251_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.848261","volume":"13","author":"O Quintana-Bustamante","year":"2022","unstructured":"Quintana-Bustamante O, Fa\u00f1anas-Baquero S, Dessy-Rodriguez M, Ojeda-P\u00e9rez I, Segovia JC. Gene editing for inherited red blood cell diseases. Front Physiol. 2022;13:848261.","journal-title":"Front Physiol"},{"issue":"1","key":"4251_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102138","volume":"35","author":"X Chen","year":"2024","unstructured":"Chen X, Du J, Yun S, Xue C, Yao Y, Rao S. Recent advances in CRISPR-Cas9-based genome insertion technologies. Mol Ther Nucleic Acids. 2024;35(1):102138.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"4251_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2024.11.001","volume":"32","author":"J Zeng","year":"2025","unstructured":"Zeng J, Nguyen MA, Liu P, da Silva LF, Levesque S, Lin LY, et al. Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells. Cell Stem Cell. 2025;32(2):191-208.e11.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"4251_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2024.02.010","volume":"31","author":"BC Lee","year":"2024","unstructured":"Lee BC, Gin A, Wu C, Singh K, Grice M, Mortlock R, et al. Impact of CRISPR\/HDR editing versus lentiviral transduction on long-term engraftment and clonal dynamics of HSPCs in rhesus macaques. Cell Stem Cell. 2024;31(4):455-66.e4.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"4251_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/03630269.2024.2369534","volume":"48","author":"B Jones-Wonni","year":"2024","unstructured":"Jones-Wonni B, Kelkar AH, Achebe MO. A review of gene therapies for hemoglobinopathies. Hemoglobin. 2024;48(3):141\u201352.","journal-title":"Hemoglobin"},{"issue":"26","key":"4251_CR54","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1182\/blood.2021011192","volume":"138","author":"J Brault","year":"2021","unstructured":"Brault J, Liu T, Bello E, Liu S, Sweeney CL, Meis RJ, et al. CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes. Blood. 2021;138(26):2768\u201380.","journal-title":"Blood"},{"key":"4251_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186461","author":"H Yang","year":"2020","unstructured":"Yang H, Ren S, Yu S, Pan H, Li T, Ge S, et al. Methods favoring homology-directed repair choice in response to CRISPR\/Cas9 induced-double strand breaks. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21186461.","journal-title":"Int J Mol Sci"},{"key":"4251_CR56","doi-asserted-by":"crossref","unstructured":"Zhang W, Chen Y, Yang J, Zhang J, Yu J, Wang M, et al. A high-throughput small molecule screen identifies farrerol as a potentiator of CRISPR\/Cas9-mediated genome editing. Elife. 2020;9.","DOI":"10.7554\/eLife.56008"},{"issue":"1","key":"4251_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nbt.4021","volume":"36","author":"MD Canny","year":"2018","unstructured":"Canny MD, Moatti N, Wan LCK, Fradet-Turcotte A, Krasner D, Mateos-Gomez PA, et al. Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency. Nat Biotechnol. 2018;36(1):95\u2013102.","journal-title":"Nat Biotechnol"},{"issue":"7601","key":"4251_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nature17664","volume":"533","author":"D Paquet","year":"2016","unstructured":"Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9. Nature. 2016;533(7601):125\u20139.","journal-title":"Nature"},{"key":"4251_CR59","doi-asserted-by":"crossref","unstructured":"Padureanu T, Coco\u0219 R, Matache IM, Bucur O. Gene-sized editing for the therapy of genetic diseases. Funct Integr Genomics. 2026;26(1).","DOI":"10.1007\/s10142-026-01823-1"},{"issue":"3","key":"4251_CR60","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul H, Altshuler D, Cappellini MD, Chen YS, Domm J, Eustace BK, et al. CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. N Engl J Med. 2021;384(3):252\u201360.","journal-title":"N Engl J Med"},{"issue":"11","key":"4251_CR61","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jgg.2024.07.004","volume":"51","author":"X Song","year":"2024","unstructured":"Song X, Liu J, Chen T, Zheng T, Wang X, Guo X. Gene therapy and gene editing strategies in inherited blood disorders. J Genet Genomics. 2024;51(11):1162\u201372.","journal-title":"J Genet Genomics"},{"issue":"18","key":"4251_CR62","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa2309673","volume":"390","author":"F Locatelli","year":"2024","unstructured":"Locatelli F, Lang P, Wall D, Meisel R, Corbacioglu S, Li AM, et al. Exagamglogene autotemcel for transfusion-dependent \u03b2-thalassemia. N Engl J Med. 2024;390(18):1663\u201376.","journal-title":"N Engl J Med"},{"issue":"18","key":"4251_CR63","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","volume":"390","author":"H Frangoul","year":"2024","unstructured":"Frangoul H, Locatelli F, Sharma A, Bhatia M, Mapara M, Molinari L, et al. Exagamglogene autotemcel for severe sickle cell disease. N Engl J Med. 2024;390(18):1649\u201362.","journal-title":"N Engl J Med"},{"issue":"7","key":"4251_CR64","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41588-023-01434-7","volume":"55","author":"T Mayuranathan","year":"2023","unstructured":"Mayuranathan T, Newby GA, Feng R, Yao Y, Mayberry KD, Lazzarotto CR, et al. Potent and uniform fetal hemoglobin induction via base editing. Nat Genet. 2023;55(7):1210\u201320.","journal-title":"Nat Genet"},{"key":"4251_CR65","doi-asserted-by":"crossref","unstructured":"Ravi NS, Wienert B, Wyman SK, Bell HW, George A, Mahalingam G, et al. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. Elife. 2022;11.","DOI":"10.7554\/eLife.65421"},{"issue":"1","key":"4251_CR66","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1038\/s41467-022-34493-1","volume":"13","author":"P Antoniou","year":"2022","unstructured":"Antoniou P, Hardouin G, Martinucci P, Frati G, Felix T, Chalumeau A, et al. Base-editing-mediated dissection of a \u03b3-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression. Nat Commun. 2022;13(1):6618.","journal-title":"Nat Commun"},{"issue":"1","key":"4251_CR67","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41467-022-35508-7","volume":"14","author":"J Liao","year":"2023","unstructured":"Liao J, Chen S, Hsiao S, Jiang Y, Yang Y, Zhang Y, et al. Therapeutic adenine base editing of human hematopoietic stem cells. Nat Commun. 2023;14(1):207.","journal-title":"Nat Commun"},{"issue":"5","key":"4251_CR68","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","volume":"7","author":"KA Everette","year":"2023","unstructured":"Everette KA, Newby GA, Levine RM, Mayberry K, Jang Y, Mayuranathan T, et al. Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. Nat Biomed Eng. 2023;7(5):616\u201328.","journal-title":"Nat Biomed Eng"},{"issue":"4","key":"4251_CR69","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ymthe.2025.02.036","volume":"33","author":"KA Wallace","year":"2025","unstructured":"Wallace KA, Gerstenberg TL, Ennis CL, Perez-Bermejo JA, Partridge JR, Bandoro C, et al. A differentiated \u03b2-globin gene replacement strategy uses heterologous introns to restore physiological expression. Mol Ther. 2025;33(4):1407\u201319.","journal-title":"Mol Ther"},{"issue":"1","key":"4251_CR70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s44307-024-00053-5","volume":"3","author":"Q Liu","year":"2025","unstructured":"Liu Q, Li X, Xu H, Luo Y, Cheng L, Liang J, et al. Therapeutic gene correction of HBB frameshift CD41-42 (-TCTT) deletion in human hematopoietic stem cells. Adv Biotechnol (Singap). 2025;3(1):2.","journal-title":"Adv Biotechnol (Singap)"},{"key":"4251_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-025-01465-x","author":"NM Fereydani","year":"2025","unstructured":"Fereydani NM, Galehdari H, Hoveizi E, Alghasi A, Ajami M, Andashti B, et al. Investigating the efficacy of the CRISPR\/Cas9 gene-editing system for targeting the HBB FSC 36-37 (-T) mutation locus in hematopoietic stem cells. Mol Biotechnol. 2025. https:\/\/doi.org\/10.1007\/s12033-025-01465-x.","journal-title":"Mol Biotechnol"},{"key":"4251_CR72","doi-asserted-by":"crossref","unstructured":"Fiesco-Roa M, Garc\u00eda-de Teresa B, Leal-Anaya P, van 't Hek R, Wegman-Ostrosky T, Fr\u00edas S, et al. Fanconi anemia and dyskeratosis congenita\/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability. Front Oncol. 2022;12:949435.","DOI":"10.3389\/fonc.2022.949435"},{"issue":"5","key":"4251_CR73","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.stem.2019.08.016","volume":"25","author":"FJ Rom\u00e1n-Rodr\u00edguez","year":"2019","unstructured":"Rom\u00e1n-Rodr\u00edguez FJ, Ugalde L, \u00c1lvarez L, D\u00edez B, Ram\u00edrez MJ, Risue\u00f1o C, et al. NHEJ-mediated repair of CRISPR-Cas9-induced DNA breaks efficiently corrects mutations in HSPCs from patients with Fanconi anemia. Cell Stem Cell. 2019;25(5):607-21.e7.","journal-title":"Cell Stem Cell"},{"key":"4251_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158416","author":"CJ Sipe","year":"2022","unstructured":"Sipe CJ, Kluesner MG, Bingea SP, Lahr WS, Andrew AA, Wang M, et al. Correction of Fanconi anemia mutations using digital genome engineering. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158416.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4251_CR75","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.1038\/s41467-022-34479-z","volume":"13","author":"SM Siegner","year":"2022","unstructured":"Siegner SM, Ugalde L, Clemens A, Garcia-Garcia L, Bueren JA, Rio P, et al. Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells. Nat Commun. 2022;13(1):6900.","journal-title":"Nat Commun"},{"issue":"1","key":"4251_CR76","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000509","volume":"5","author":"BC Houghton","year":"2021","unstructured":"Houghton BC, Booth C. Gene therapy for primary immunodeficiency. Hemasphere. 2021;5(1):e509.","journal-title":"Hemasphere"},{"issue":"6","key":"4251_CR77","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41573-019-0020-9","volume":"18","author":"M Cavazzana","year":"2019","unstructured":"Cavazzana M, Bushman FD, Miccio A, Andr\u00e9-Schmutz I, Six E. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat Rev Drug Discov. 2019;18(6):447\u201362.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"4251_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102229","volume":"35","author":"KM Siow","year":"2024","unstructured":"Siow KM, G\u00fcng\u00f6r M, Wrona D, Raimondi F, Pastukhov O, Tsapogas P, et al. Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 (phox) -deficient chronic granulomatous disease. Mol Ther Nucleic Acids. 2024;35(3):102229.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"769","key":"4251_CR79","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj6779","volume":"16","author":"V Bzhilyanskaya","year":"2024","unstructured":"Bzhilyanskaya V, Ma L, Liu S, Fox LR, Whittaker MN, Meis RJ, et al. High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease. Sci Transl Med. 2024;16(769):eadj6779.","journal-title":"Sci Transl Med"},{"key":"4251_CR80","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1182\/blood-2023-186365","volume":"142","author":"JM Heath","year":"2023","unstructured":"Heath JM, Orenstein JS, Tedeschi JG, Ng A, Collier MD, Kushakji J, et al. Prime editing efficiently and precisely corrects causative mutation in chronic granulomatous disease, restoring myeloid function: toward development of a prime edited autologous hematopoietic stem cell therapy. Blood. 2023;142:7129.","journal-title":"Blood"},{"issue":"1","key":"4251_CR81","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jaci.2023.08.003","volume":"153","author":"V Dettmer-Monaco","year":"2024","unstructured":"Dettmer-Monaco V, Wei\u00dfert K, Ammann S, Monaco G, Lei L, Gr\u00e4\u00dfel L, et al. Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. 2024;153(1):243-55.e14.","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"4251_CR82","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz0571","volume":"6","author":"M Goodwin","year":"2020","unstructured":"Goodwin M, Lee E, Lakshmanan U, Shipp S, Froessl L, Barzaghi F, et al. CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells. Sci Adv. 2020;6(19):eaaz0571.","journal-title":"Sci Adv"},{"issue":"6","key":"4251_CR83","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.ymthe.2024.04.005","volume":"32","author":"YR Li","year":"2024","unstructured":"Li YR, Zhou Y, Yu J, Zhu Y, Lee D, Zhu E, et al. Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy. Mol Ther. 2024;32(6):1849\u201374.","journal-title":"Mol Ther"},{"issue":"13","key":"4251_CR84","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","volume":"381","author":"L Xu","year":"2019","unstructured":"Xu L, Wang J, Liu Y, Xie L, Su B, Mou D, et al. CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia. N Engl J Med. 2019;381(13):1240\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"4251_CR85","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-025-55873-3","volume":"16","author":"DT Claiborne","year":"2025","unstructured":"Claiborne DT, Detwiler Z, Docken SS, Borland TD, Cromer D, Simkhovich A, et al. High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection. Nat Commun. 2025;16(1):446.","journal-title":"Nat Commun"},{"issue":"7","key":"4251_CR86","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","volume":"24","author":"E Haapaniemi","year":"2018","unstructured":"Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med. 2018;24(7):927\u201330.","journal-title":"Nat Med"},{"issue":"11","key":"4251_CR87","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/stmcls\/sxae056","volume":"42","author":"YD Sun","year":"2024","unstructured":"Sun YD, Li GH, Zhang F, Cheng T, Zhang JP, Zhang XB. A p21 reporter iPSC line for evaluating CRISPR-Cas9 and vector-induced stress responses. Stem Cells. 2024;42(11):992\u20131005.","journal-title":"Stem Cells"},{"issue":"12","key":"4251_CR88","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41573-025-01236-y","volume":"24","author":"S Levesque","year":"2025","unstructured":"Levesque S, Bauer DE. CRISPR-based therapeutic genome editing for inherited blood disorders. Nat Rev Drug Discov. 2025;24(12):907\u201325.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"4251_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102157","volume":"6","author":"A Conti","year":"2025","unstructured":"Conti A, Giannetti K, Midena F, Beretta S, Gualandi N, De Marco R, et al. Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9\/AAV6-mediated gene editing in hematopoietic stem cells. Cell Rep Med. 2025;6(6):102157.","journal-title":"Cell Rep Med"},{"issue":"11","key":"4251_CR90","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1093\/nar\/gku402","volume":"42","author":"Y Lin","year":"2014","unstructured":"Lin Y, Cradick TJ, Brown MT, Deshmukh H, Ranjan P, Sarode N, et al. CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res. 2014;42(11):7473\u201385.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4251_CR91","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41588-022-01257-y","volume":"55","author":"S Cancellieri","year":"2023","unstructured":"Cancellieri S, Zeng J, Lin LY, Tognon M, Nguyen MA, Lin J, et al. Human genetic diversity alters off-target outcomes of therapeutic gene editing. Nat Genet. 2023;55(1):34\u201343.","journal-title":"Nat Genet"},{"issue":"2","key":"4251_CR92","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/nar\/gkx1199","volume":"46","author":"DE Ryan","year":"2018","unstructured":"Ryan DE, Taussig D, Steinfeld I, Phadnis SM, Lunstad BD, Singh M, et al. Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs. Nucleic Acids Res. 2018;46(2):792\u2013803.","journal-title":"Nucleic Acids Res"},{"key":"4251_CR93","doi-asserted-by":"publisher","first-page":"1065377","DOI":"10.3389\/fmed.2022.1065377","volume":"9","author":"P Zarghamian","year":"2022","unstructured":"Zarghamian P, Klermund J, Cathomen T. Clinical genome editing to treat sickle cell disease-A brief update. Front Med (Lausanne). 2022;9:1065377.","journal-title":"Front Med (Lausanne)"},{"key":"4251_CR94","doi-asserted-by":"publisher","first-page":"1143157","DOI":"10.3389\/fbioe.2023.1143157","volume":"11","author":"C Guo","year":"2023","unstructured":"Guo C, Ma X, Gao F, Guo Y. Off-target effects in CRISPR\/Cas9 gene editing. Front Bioeng Biotechnol. 2023;11:1143157.","journal-title":"Front Bioeng Biotechnol"},{"issue":"12","key":"4251_CR95","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41587-022-01377-0","volume":"40","author":"AD Nahmad","year":"2022","unstructured":"Nahmad AD, Reuveni E, Goldschmidt E, Tenne T, Liberman M, Horovitz-Fried M, et al. Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage. Nat Biotechnol. 2022;40(12):1807\u201313.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"4251_CR96","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","volume":"28","author":"G Turchiano","year":"2021","unstructured":"Turchiano G, Andrieux G, Klermund J, Blattner G, Pennucci V, El Gaz M, et al. Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq. Cell Stem Cell. 2021;28(6):1136-47.e5.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4251_CR97","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/s41467-019-09006-2","volume":"10","author":"G Cullot","year":"2019","unstructured":"Cullot G, Boutin J, Toutain J, Prat F, Pennamen P, Rooryck C, et al. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations. Nat Commun. 2019;10(1):1136.","journal-title":"Nat Commun"},{"issue":"6","key":"4251_CR98","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","volume":"53","author":"ML Leibowitz","year":"2021","unstructured":"Leibowitz ML, Papathanasiou S, Doerfler PA, Blaine LJ, Sun L, Yao Y, et al. Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing. Nat Genet. 2021;53(6):895\u2013905.","journal-title":"Nat Genet"},{"key":"4251_CR99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004832117","author":"G Alanis-Lobato","year":"2021","unstructured":"Alanis-Lobato G, Zohren J, McCarthy A, Fogarty NME, Kubikova N, Hardman E, et al. Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2004832117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4251_CR100","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00439-023-02610-9","volume":"142","author":"S Zeng","year":"2023","unstructured":"Zeng S, Lei S, Qu C, Wang Y, Teng S, Huang P. CRISPR\/Cas-based gene editing in therapeutic strategies for beta-thalassemia. Hum Genet. 2023;142(12):1677\u2013703.","journal-title":"Hum Genet"},{"issue":"11","key":"4251_CR101","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jcyt.2024.06.002","volume":"26","author":"AO Gupta","year":"2024","unstructured":"Gupta AO, Azul M, Bhoopalan SV, Abraham A, Bertaina A, Bidgoli A, et al. International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced. Cytotherapy. 2024;26(11):1411\u201320.","journal-title":"Cytotherapy"},{"issue":"13","key":"4251_CR102","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.cell.2022.04.039","volume":"185","author":"A Omer-Javed","year":"2022","unstructured":"Omer-Javed A, Pedrazzani G, Albano L, Ghaus S, Latroche C, Manzi M, et al. Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells. Cell. 2022;185(13):2248-64.e21.","journal-title":"Cell"},{"issue":"1","key":"4251_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.stem.2024.10.013","volume":"32","author":"D Araki","year":"2025","unstructured":"Araki D, Chen V, Redekar N, Salisbury-Ruf C, Luo Y, Liu P, et al. Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response. Cell Stem Cell. 2025;32(1):53-70.e8.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"4251_CR104","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41587-022-01527-4","volume":"41","author":"MTN Yarnall","year":"2023","unstructured":"Yarnall MTN, Ioannidi EI, Schmitt-Ulms C, Krajeski RN, Lim J, Villiger L, et al. Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases. Nat Biotechnol. 2023;41(4):500\u201312.","journal-title":"Nat Biotechnol"},{"issue":"18","key":"4251_CR105","doi-asserted-by":"publisher","first-page":"10590","DOI":"10.1093\/nar\/gkaa779","volume":"48","author":"S Ma","year":"2020","unstructured":"Ma S, Wang X, Hu Y, Lv J, Liu C, Liao K, et al. Enhancing site-specific DNA integration by a Cas9 nuclease fused with a DNA donor-binding domain. Nucleic Acids Res. 2020;48(18):10590\u2013601.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"4251_CR106","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jtct.2022.08.029","volume":"28","author":"A Sharma","year":"2022","unstructured":"Sharma A, Farnia S, Otegbeye F, Rinkle A, Shah J, Shah NN, et al. Nomenclature for cellular and genetic therapies: a need for standardization. Transplant Cell Ther. 2022;28(12):795\u2013801.","journal-title":"Transplant Cell Ther"},{"issue":"18","key":"4251_CR107","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1182\/bloodadvances.2019000516","volume":"3","author":"C Gao","year":"2019","unstructured":"Gao C, Schroeder JA, Xue F, Jing W, Cai Y, Scheck A, et al. Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Adv. 2019;3(18):2700\u201311.","journal-title":"Blood Adv"},{"key":"4251_CR108","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.exphem.2021.01.003","volume":"95","author":"NF Russkamp","year":"2021","unstructured":"Russkamp NF, Myburgh R, Kiefer JD, Neri D, Manz MG. Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells. Exp Hematol. 2021;95:31\u201345.","journal-title":"Exp Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04251-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:05:27Z","timestamp":1788188727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04251-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04251-w","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report there are no competing interests to declare.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Therefore, ethical approval was not required for this review.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final version of the manuscript. We agree to submit this manuscript to stem cell research and therapy for consideration for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}